Physician profile
Ryan Peter Cotter
NPI 1467879726
$4,717.68
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,699 · 2020: $423 · 2021: $332 · 2022: $974 · 2023: $69.82 · 2024: $220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $290.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $290.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,596.58 | 2019-2021 | |
| Abbott Laboratories | $1,019.20 | 2019-2024 | Mitraclip |
| Novartis Pharmaceuticals Corporation | $288.04 | 2022-2024 | |
| Philips North America LLC | $98.99 | 2020-2024 | (Ck4) Mcot |
| Amgen INC. | $92.49 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $70.78 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $69.42 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $64.83 | 2020-2022 | |
| Pfizer INC. | $53.62 | 2022 | |
| Esperion Therapeutics, INC. | $50.37 | 2020-2022 | |
| Impulse Dynamics (USA) INC. | $46.69 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $46.51 | 2020-2022 | |
| Heartflow, INC. | $43.88 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $43.48 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $34.77 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $29.55 | 2022 | |
| Amarin Pharma, INC. | $22.34 | 2021 | |
| Arbor Pharmaceuticals, INC. | $20.36 | 2021 | |
| Lantheus Medical Imaging, INC. | $13.14 | 2023 | Definity |
| Merck Sharp & Dohme LLC | $12.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Cotter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.